Prospective Risk Adjustment

Turn every encounter into a prospective risk opportunity

Evidence-based insights healthcare providers can trust

Reveleer Prospective Risk Adjustment delivers the insights you need to close diagnosis and care gaps at every point along the patient encounter lifecycle. The result is improved documentation accuracy, stronger quality performance, and audit-ready documentation that fits how teams already work.

Actionable insights before, during, and after visits

Prospective Risk Adjustment supports CDI pre-visit review, point-of-care insights, and post-visit pre-bill checks. Each encounter becomes a chance to address diagnosis gaps and care gaps in real time instead of chasing issues months later.

From black-box scores to clinically meaningful opportunities

Where traditional NLP tools rely on vague probability bands, Reveleer EVETM Hybrid AI starts with clinical authority: 11,000 clinical indicators  turn chart noise into a short list of high-value suspects that carry clear, defensible proof.

How Prospective Risk Adjustment changes the visit

See how Reveleer Prospective Risk Adjustment surfaces diagnosis gaps and care gaps in your EHR so providers work from the same evidence-backed view of each patient, with fewer interruptions and more clinically meaningful insights.

How It Works

Prospective Risk Adjustment that keeps providers in their flow

Real-time prospective risk drives measurable financial and clinical impact

Achieve better value-based care performance by addressing diagnosis and care gaps during point-of-care visits with Reveleer Prospective Risk Adjustment.

6X ROI and $18.5M in enhanced revenue capture

A large not-for-profit health system used Reveleer’s point-of-care suspecting to improve its suspect HCC provider address rate by 34 percent in one year, generating a 6X return on investment and $18.5 million in additional revenue capture.

3X less noise than traditional NLP suspecting

Benchmarks of EVE Hybrid AI includes up to 3X less suspect “noise” for providers than legacy NLP workflows, with every recommendation tied to explicit source evidence and transparent logic.

55% increase in HCC capture per patient

By combining AI and CDI resources, health systems experience a significant increase in efficiency, making the best use of highly constrained staff time.

Case Study

Information quality over quantity for optimal use of CDI resources

Read Now

Prospective risk, reimagined

Drowning in false positives and black-box suspects? With EVE™ Hybrid AI powering Prospective Risk Adjustment, noise drops by up to 3X vs. legacy NLP, so clinicians and coding teams can focus on the most relevant, evidence-backed suspects tied to clear, traceable source documentation. Get a demo to watch suspects flow through an audit-ready evidence graph and turn “why is this flagged?” into fast, defensible action.

Prospective Risk Adjustment software that works for providers

Multi-model, multi-EHR support

Reveleer supports CMS V28, HHS V08, and other key models and integrates with Epic, athenahealth, and more. Portals, overlays, and data exhaust mean your teams see information when and where they need it.

Visit-aligned advisories for CDI, providers, and coders

Support CDI pre-visit review, provider point-of-care advisories, and coder pre-bill checks with one consistent set of evidence-backed insights. Improve documentation quality and reduce rework for busy care teams.

Analytics from enterprise to encounter

Track RAF projections, suspect performance, and provider engagement with executive, network, and operational dashboards. Easily identify what is working and where to intervene.

The basics of Prospective Risk Adjustment

Prospective Risk Adjustment helps risk-bearing organizations surface diagnosis gaps at the point of care to proactively address gaps in care and improve patient outcomes. Retrospective programs rely on post-claim reviews that can result in administrative burden and missed opportunities. Prospective Risk Adjustment can supplement retrospective audits by delivering an accurate picture of patient health well ahead of retrospective deadlines.

EVE Hybrid AI separates evidence extraction from clinical decision-making and uses clinician-owned formulas plus specialty-specific logic, which significantly reduces noise and focuses advisories on high-value, clinically relevant opportunities.

Insights may include existing diagnoses for recapture, potential diagnoses for consideration, and open care gaps, each backed by specific clinical indicators and clear next steps.

Every suspect and gap is linked to its source documentation and the formulas that generated it, creating a transparent, traceable record that aligns with AHIMA and ACDIS guidance for compliant queries.

Reveleer supports CMS V28 and additional models such as HHS V08 and Medicaid CDPS Rx, with coverage expanding over time to support key value-based contracts across Medicare Advantage, ACA, Medicaid, and Commercial.

Depending on data readiness and delivery method, prospective risk programs can go live in as little as six to twelve weeks after production data is available, with options for portal access, direct EHR integration, or overlays.

When CMS or HHS models change, clinical rules can be updated in days rather than months, without retraining AI models, so suspecting stays current while your teams stay focused on patient care instead of rule rewrites.